Navigation Links
Verenium Corporation To Announce Second Quarter 2013 Financial Results
Date:7/25/2013

SAN DIEGO, July 25, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it will release second quarter 2013 financial results on Wednesday, August 7, 2013 after market close. In conjunction with the release, the Company will host a conference call with live webcast on Wednesday, August 7, 2013 at 5:00 p.m. ET.

(Logo:  http://photos.prnewswire.com/prnh/20120924/MM79973LOGO)

The call may be accessed by dialing (877) 755-7422 (domestic) or (678) 894-3067 (international) five minutes prior to start time and providing the passcode 19911712.  A link to the live webcast may be accessed by visiting the "Investors" section of the Company's website at http://ir.verenium.com/.  A replay of the event will be available on the Company's website approximately two hours after the call and will be archived for 30 days.

About Verenium
Verenium, an industrial biotechnology company, is a global leader in developing high-performance enzymes.  Verenium's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries, including the global food and fuel markets.  Read more at www.verenium.com.

Forward Looking Statements
Statements in this press release that are not strictly historical are "forward-looking" and involve a high degree of risk and uncertainty.  These include, but are not limited to, statements related to Verenium's estimated revenues, operating loss and capital expenditures for the year ended December 31, 2012, unrestricted cash balance as of Dec
'/>"/>

SOURCE Verenium Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Verenium Announces Appointment Of Brian Carter As Vice President Of Grain Processing
2. Verenium To Sponsor And Present At The 2013 Bio World Congress On Industrial Biotechnology
3. Verenium To Introduce New Enzyme Product At 2013 International Fuel Ethanol Workshop & Expo
4. Verenium To Present At Two Upcoming Conferences
5. Verenium Corporation to Announce First Quarter 2013 Financial Results
6. Verenium Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2012
7. Verenium Announces Preliminary Financial Results For Fiscal 2012
8. Verenium To Present At The 25Th Annual Roth Conference
9. Verenium Appoints Holger Liepmann To Its Board Of Directors
10. Verenium To Sponsor The Renewable Fuels Association 18th Annual National Ethanol Conference
11. Novus International And Verenium Announce Important Progress In The Development Of Novel Enzymes For Animal Health & Nutrition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ), a ... for the quarter ending June 30, 2015. Highlights included: ... 2015 , The final cost of the Sarnia ... million above the high end of the estimate communicated ... 10%) , The company announced commercial collaborations in ...
(Date:8/4/2015)... 4, 2015 According to ... titled, "World Cardiac Biomarker - Market Opportunities, and ... generate the revenue of $2,085.9 million by 2020, ... 2020. Cardiac Troponins (T, I) would continue to ... to high sensitivity and specificity.      ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... point-of-care (POC) diagnostic tests – today announced that Robert A. Gregg, PhD, has ... has more than 30 years of relevant experience and remarkable achievements in the ...
(Date:8/4/2015)... -- Blueprint Medicines (NASDAQ: BPMC ), a leader in ... defined diseases, today announced that Jeffrey Albers , ... the 2015 Wedbush PacGrow Healthcare Conference on Tuesday, August ... live webcast of the event will be available by ... at www.blueprintmedicines.com . An archived replay of the ...
Breaking Biology Technology:BioAmber Reports Second Quarter 2015 Financial Results 2BioAmber Reports Second Quarter 2015 Financial Results 3BioAmber Reports Second Quarter 2015 Financial Results 4BioAmber Reports Second Quarter 2015 Financial Results 5BioAmber Reports Second Quarter 2015 Financial Results 6BioAmber Reports Second Quarter 2015 Financial Results 7BioAmber Reports Second Quarter 2015 Financial Results 8BioAmber Reports Second Quarter 2015 Financial Results 9BioAmber Reports Second Quarter 2015 Financial Results 10BioAmber Reports Second Quarter 2015 Financial Results 11BioAmber Reports Second Quarter 2015 Financial Results 12Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 2Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 3Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 4Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 5RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 2RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 3
... May 17, 2011 Today, Molecular Devices, a leading ... and life sciences research, announced that NanoRacks, LLC has ... in NASA,s International Space Station; the M5e Reader will ... space. (Logo:   http://photos.prnewswire.com/prnh/20100406/SF82092LOGO ...
... May 16, 2011 Renowned actor and martial artist Steven ... Vladimir Putin, asking the Prime Minister,s support of the "Russia ... immortality and artificial body research. According to Seagal, "Russia 2045," ... the quality of life and make humans immortal by the ...
... 16, 2011 Children taking medication for attention deficit ... or heart-related deaths than those who were not taking ... in the journal, Pediatrics . ... of Pennsylvania and HealthCore Inc., drew data from the ...
Cached Biology Technology:Molecular Devices' SpectraMax® M5e Multi-Mode Microplate Reader Chosen to be the First Microplate Reader in Space by NanoRacks, LLC for NASA's International Space Station 2Molecular Devices' SpectraMax® M5e Multi-Mode Microplate Reader Chosen to be the First Microplate Reader in Space by NanoRacks, LLC for NASA's International Space Station 3Molecular Devices' SpectraMax® M5e Multi-Mode Microplate Reader Chosen to be the First Microplate Reader in Space by NanoRacks, LLC for NASA's International Space Station 4Steven Seagal Asks For Russian PM Vladimir Putin's Support in Immortality Research 2Pediatrics Study Finds Children Taking ADHD Medications Did Not Suffer More Serious Heart Problems or Cardiovascular-related Death 2Pediatrics Study Finds Children Taking ADHD Medications Did Not Suffer More Serious Heart Problems or Cardiovascular-related Death 3
(Date:7/27/2015)... , July 27, 2015  Synaptics Inc. ... human interface solutions, today announced that Huawei has ... touchscreen solution for its stylish smartwatch. Huawei chose ... proven reliability, low power and highly responsive human ... finger. Huawei designers also required a classic round ...
(Date:7/23/2015)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its second quarter ended June 30, 2015.  ... a decrease of 33% compared to $6.8 million in the ... of 2015 was $0.3 million, or $0.01 per diluted share, ... in the same period a year ago.  ...
(Date:7/21/2015)... GOTHENBURG, Sweden , July 21, 2015 ... sensor FPC1025. Already received as well as expected revenues in 2015 ... included in FPC,s communicated revenue guidance of approximately 2,200 MSEK for ... is a leading smartphone manufacturer in China ... selected FPC1 02 5 for Axon ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2
... membranes form the "skin" of most every cell in your ... in motion cannot be rendered by many experimental techniques. A ... and Technology (NIST) and University of California, Irvine, recently developed ... illuminate the important role of cholesterol within this boundary between ...
... Scientists from the United States and China have discovered ... type of flowering plant whose membership includes buttercups, apple ... find, described in this week,s Nature, reveals a remarkably ... earlier origin of the eudicots -- and perhaps flowering ...
... figures in the nuclear industry will be led by Maurie ... at NJIT. "Panelists will look at the current ... emergent implications of the disaster," Cohen said. "Speakers will discuss ... the nuclear facilities and the health implications." The public ...
Cached Biology News:Closer look at cell membrane shows cholesterol 'keeping order' 2Fossil is best look yet at an ancestor of buttercups 2Fossil is best look yet at an ancestor of buttercups 3Public forum: Japan and early lessons for the nuclear industry 2
... assay (ELISA) test kits are qualitative ... the detection of drugs and/or their metabolites ... for forensic use only. It is recommended ... a quantitative method such as GC/MS. ...
... RNase Inhibitor (patent pending) is a protein ... binds and inhibits the most common and ... 1 and T1. SUPERaseIn can be used ... be problematic. It is ideal for in ...
... Ribonuclease Inhibitor is a recombinant protein that has ... RNA in the preparation of cDNA by reverse ... vitro protein synthesis. RNA Safe Inhibitor tightly binds ... broad range of eukaryotic RNases such as RNase ...
... (Ribonuclease inhibitor) is a 50 ... inhibit RNase activity. It does ... activity. , Inhibits RNase ... template , Lacks DNA ...
Biology Products: